707
Views
4
CrossRef citations to date
0
Altmetric
Research Papers

Prevalence of upper-limb spasticity and its impact on care among nursing home residents with prior stroke

, , , &
Pages 2170-2177 | Received 21 Aug 2018, Accepted 30 Nov 2018, Published online: 31 Mar 2019

References

  • Lance JW. The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology. 1980;30:1303–1313.
  • Brainin M, Norrving B, Sunnerhagen KS, et al. Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications. Int J Stroke. 2011;6:42–46.
  • Sommerfeld DK, Eek EU, Svensson AK, et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke. 2004;35:134–139.
  • Yelnik AP, Colle FM, Bonan IV, et al. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry. 2007;78:845–848.
  • Gillard PJ, Sucharew H, Kleindorfer D, et al. The negative impact of spasticity on the health-related quality of life of stroke survivors: a longitudinal cohort study. Health Qual Life Outcomes. 2015;13:159.
  • Urban PP, Wolf T, Uebele M, et al. Occurence and clinical predictors of spasticity after ischemic stroke. Stroke. 2010;41:2016–2020.
  • Lundstrom E, Smits A, Borg J, et al. Four-fold increase in direct costs of stroke survivors with spasticity compared with stroke survivors without spasticity: the first year after the event. Stroke. 2010;41:319–324.
  • Ganapathy V, Graham GD, DiBonaventura MD, et al. Caregiver burden, productivity loss, and indirect costs associated with caring for patients with poststroke spasticity. Clin Interv Aging. 2015;10:1793–1802.
  • Denno MS, Gillard PJ, Graham GD, et al. Anxiety and depression associated with caregiver burden in caregivers of stroke survivors with spasticity. Arch Phys Med Rehabil. 2013;94:1731–1736.
  • Lundstrom E, Terent A, Borg J. Prevalence of disabling spasticity 1 year after first-ever stroke. Eur J Neurol. 2008;15:533–539.
  • Watkins CL, Leathley MJ, Gregson JM, et al. Prevalence of spasticity post stroke. Clin Rehabil. 2002;16:515–522.
  • Wissel J, Schelosky LD, Scott J, et al. Early development of spasticity following stroke: a prospective, observational trial. J Neurol. 2010;257:1067–1072.
  • Meijer R, Wolswijk A, Eijsden HV. Prevalence, impact and treatment of spasticity in nursing home patients with central nervous system disorders: a cross-sectional study. Disabil Rehabil. 2017;39:363–371.
  • AIHW. Stroke and its management in Australia: an update Cardiovascular disease series no 37 Cat No CVD 61. Canberra, Australia: AIHW; 2013.
  • Cowman S, Royston M, Hickey A, et al. Stroke and nursing home care: a national survey of nursing homes. BMC Geriatr. 2010;10:4.
  • van Almenkerk S, Depla MF, Smalbrugge M, et al. Institutionalized stroke patients: status of functioning of an under researched population. J Am Med Dir Assoc. 2012;13:634–639.
  • Callahan CM, Unverzagt FW, Hui SL, et al. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care. 2002;40:771–781.
  • Patrick E, Ada L. The Tardieu Scale differentiates contracture from spasticity whereas the Ashworth Scale is confounded by it. Clin Rehabil. 2006;20:173–182.
  • Abbey J, Piller N, De Bellis A, et al. The Abbey pain scale: a 1-minute numerical indicator for people with end-stage dementia. Int J Palliat Nurs. 2004;10:6–13.
  • Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14:798–804.
  • McCaffery M, Beebe A. Pain: clinical manual for nursing practice. St Louis, MO: Mosby; 1989.
  • van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–607.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
  • Ashford S, Slade M, Turner-Stokes L. Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm. Disabil Rehabil. 2013;35:1513–1518.
  • Ashford S, Turner-Stokes L, Siegert R, et al. Initial psychometric evaluation of the Arm Activity Measure (ArmA): a measure of activity in the hemiparetic arm. Clin Rehabil. 2013;27:728–740.
  • Francis HP, Wade DT, Turner-Stokes L, et al. Does reducing spasticity translate into functional benefit? An exploratory meta- analysis. J Neurol Neurosurg Psychiatry. 2004;75:1547–1551.
  • Turner-Stokes L, Baguley IJ, De Graaff S, et al. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial. J Rehabil Med. 2010;42:81–89.
  • Van Rensbergen G, Nawrot T. Medical conditions of nursing home admissions. BMC Geriatr. 2010;10:46.
  • Sackley C, Brittle N, Patel S, et al. The prevalence of joint contractures, pressure sores, painful shoulder, other pain, falls, and depression in the year after a severely disabling stroke. Stroke 2008;39:3329–3334.
  • van Almenkerk S, Depla MF, Smalbrugge M, et al. Pain among institutionalized stroke patients and its relation to emotional distress and social engagement. Int J Geriatr Psychiatry. 2015;30:1023–1031.
  • Dehail P, Simon O, Godard AL, et al. Acquired deforming hypertonia and contractures in elderly subjects: definition and prevalence in geriatric institutions (ADH survey). Ann Phys Rehabil Med. 2014;57:11–23.
  • Lam K, Lau KK, So KK, et al. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study. J Am Med Dir Assoc. 2012;13:477–484.
  • Stroke Foundation. Clinical guidelines for stroke management 2017, Melbourne, Australia, 2017.
  • Sheean G, Lannin NA, Turner-Stokes L, et al. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol. 2010;17:74–93.
  • Foley N, Pereira S, Salter K, et al. Treatment with botulinum toxin improves upper-extremity function post stroke: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2013;94:977–989.
  • Cotoi A, Illiescu A, Foley N, et al. Upper extremity interventions. Evidence-Based Review of Stroke Rehabilitation (EBRSR) [Internet]. 2018 [cited 2018 Apr 2]. Available from: http://www.ebrsr.com/sites/default/files/v18-SREBR-CH10-NET.pdf.
  • Smith LN, Craig LE, Weir CJ, et al. The evidence-base for stroke education in care homes. Nurse Educ Today. 2008;28:829–840.
  • Noone I, Fan CW, Tarrant H, et al. What happens to stroke patients after hospital discharge? Ir Med J. 2001;94:151–152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.